Vi typhoid vaccine proves highly effective in youn...(ogistically and programmatically possibl...)

Date:7/22/2009

ogistically and programmatically possible. "The fact that the level of overall protection (57 percent) was similar to the adjusted level of total protection among vaccinees (61 percent), despite vaccine coverage of only about 60 percent of the subjects, underscores the importance of herd protection by the Vi vaccine," said Dr. Clemens, a co-author of the study. "It also suggests the need for consideration of herd protective effects in future deliberations about the use of this vaccine in developing countries."

Meanwhile, in a separate vaccine development project, IVI laboratories have more than tripled the manufacturing yield of Vi polysaccharide, which is expected to further reduce the vaccine's production cost, thus making it more accessible for developing countries. The production technology for the high-yield Vi polysaccharide is being transferred to high-quality producers in developing countries.

'/>"/>

Contact: Tae Kyung Byun tkbyun@ivi.int 82-119-773-6071 International Vaccine Institute Source:Eurekalert

0 GOOD

Page: 1 2 3
Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
3. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
4. Anthrax vaccine produces immunity with nanoparticles, not needles
5. FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox
6. International Scientific Workshop Focuses on New Methods for Vaccine and Antibody Development
7. The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine
8. Sanofi Pasteurs Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage
9. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
10. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
11. New nanoparticle vaccine is more effective but less expensive